Italian drugmaker Chiesi to buy KalVista for $1.9 billion
April 29 (Reuters) - Italy's Chiesi has agreed to buy KalVista Pharmaceuticals KALV.O for about $1.9 billion, the company said on Wednesday, as it looks to grow its rare disease drug portfolio. (Reporting by Kamal Choudhury in Bengaluru; Editing by Shailesh Kuber) ((Kamal.Choudhury@thomsonreuters.com;))
Recent news on Kalvista Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 08:36 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Seagate, GE Healthcare, Bloom Energy